HPV nel carcinoma dell’orofaringe: Le nozioni base da conoscere nella pratica clinica

Translated title of the contribution: HPV in oropharyngeal cancer: The basics to know in clinical practice

S. Elrefaey, M. A. Massaro, S. Chiocca, F. Chiesa, Mohssen Ansarin

Research output: Contribution to journalArticle

Abstract

The incidence of oropharyngeal squamous cell carcinoma (OPSCC) is rising in contrast to the decreasing incidence of carcinomas in other subsites of the head and neck, in spite of the reduced prevalence of smoking. Human papilloma virus (HPV) infection, and in particular type 16 (HPV-16), is now recognized as a significant player in the onset of HPV positive OPSCC, with different epidemiological, clinical, anatomical, radiological, behavioural, biological and prognostic characteristics from HPV negative OPSCC. Indeed, the only subsite in the head and neck with a demonstrated aetiological viral link is, at present, the oropharynx. These observations lead to questions regarding management choices for patients based on tumour HPV status with important consequences on treatment, and on the role of vaccines and targeted therapy over the upcoming years.

Original languageItalian
Pages (from-to)299-309
Number of pages11
JournalActa Otorhinolaryngologica Italica
Volume34
Issue number5
Publication statusPublished - Oct 1 2014

Fingerprint

Papillomaviridae
Oropharyngeal Neoplasms
Squamous Cell Carcinoma
Neck
Head
Active Immunotherapy
Oncogenic Viruses
Oropharynx
Incidence
Virus Diseases
Smoking
Carcinoma

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

HPV nel carcinoma dell’orofaringe : Le nozioni base da conoscere nella pratica clinica. / Elrefaey, S.; Massaro, M. A.; Chiocca, S.; Chiesa, F.; Ansarin, Mohssen.

In: Acta Otorhinolaryngologica Italica, Vol. 34, No. 5, 01.10.2014, p. 299-309.

Research output: Contribution to journalArticle

@article{a8947f1dbe214cc182dfc9b58fb9a9c1,
title = "HPV nel carcinoma dell’orofaringe: Le nozioni base da conoscere nella pratica clinica",
abstract = "The incidence of oropharyngeal squamous cell carcinoma (OPSCC) is rising in contrast to the decreasing incidence of carcinomas in other subsites of the head and neck, in spite of the reduced prevalence of smoking. Human papilloma virus (HPV) infection, and in particular type 16 (HPV-16), is now recognized as a significant player in the onset of HPV positive OPSCC, with different epidemiological, clinical, anatomical, radiological, behavioural, biological and prognostic characteristics from HPV negative OPSCC. Indeed, the only subsite in the head and neck with a demonstrated aetiological viral link is, at present, the oropharynx. These observations lead to questions regarding management choices for patients based on tumour HPV status with important consequences on treatment, and on the role of vaccines and targeted therapy over the upcoming years.",
keywords = "Clinical Trial, Head and Neck cancer, Human Papillomavirus, Oropharyngeal cancer, Prevention, Prognosis, Squamous Cell Carcinoma, Treatment, Vaccination",
author = "S. Elrefaey and Massaro, {M. A.} and S. Chiocca and F. Chiesa and Mohssen Ansarin",
year = "2014",
month = "10",
day = "1",
language = "Italian",
volume = "34",
pages = "299--309",
journal = "Acta Otorhinolaryngologica Italica",
issn = "0392-100X",
publisher = "Pacini Editore s.r.l.",
number = "5",

}

TY - JOUR

T1 - HPV nel carcinoma dell’orofaringe

T2 - Le nozioni base da conoscere nella pratica clinica

AU - Elrefaey, S.

AU - Massaro, M. A.

AU - Chiocca, S.

AU - Chiesa, F.

AU - Ansarin, Mohssen

PY - 2014/10/1

Y1 - 2014/10/1

N2 - The incidence of oropharyngeal squamous cell carcinoma (OPSCC) is rising in contrast to the decreasing incidence of carcinomas in other subsites of the head and neck, in spite of the reduced prevalence of smoking. Human papilloma virus (HPV) infection, and in particular type 16 (HPV-16), is now recognized as a significant player in the onset of HPV positive OPSCC, with different epidemiological, clinical, anatomical, radiological, behavioural, biological and prognostic characteristics from HPV negative OPSCC. Indeed, the only subsite in the head and neck with a demonstrated aetiological viral link is, at present, the oropharynx. These observations lead to questions regarding management choices for patients based on tumour HPV status with important consequences on treatment, and on the role of vaccines and targeted therapy over the upcoming years.

AB - The incidence of oropharyngeal squamous cell carcinoma (OPSCC) is rising in contrast to the decreasing incidence of carcinomas in other subsites of the head and neck, in spite of the reduced prevalence of smoking. Human papilloma virus (HPV) infection, and in particular type 16 (HPV-16), is now recognized as a significant player in the onset of HPV positive OPSCC, with different epidemiological, clinical, anatomical, radiological, behavioural, biological and prognostic characteristics from HPV negative OPSCC. Indeed, the only subsite in the head and neck with a demonstrated aetiological viral link is, at present, the oropharynx. These observations lead to questions regarding management choices for patients based on tumour HPV status with important consequences on treatment, and on the role of vaccines and targeted therapy over the upcoming years.

KW - Clinical Trial

KW - Head and Neck cancer

KW - Human Papillomavirus

KW - Oropharyngeal cancer

KW - Prevention

KW - Prognosis

KW - Squamous Cell Carcinoma

KW - Treatment

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=84983571355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983571355&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:84983571355

VL - 34

SP - 299

EP - 309

JO - Acta Otorhinolaryngologica Italica

JF - Acta Otorhinolaryngologica Italica

SN - 0392-100X

IS - 5

ER -